CVI Holdings »

Immunitybio shares owned by CVI Holdings

Quarter-by-quarter ownership of Immunitybio (IBRX) shares owned by CVI Holdings from 13F filings

Historical chart of CVI Holdings investment in Immunitybio

Tip: Access up to 7 years of quarterly data

All positions including Immunitybio held by CVI Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunitybio by CVI Holdings

Quarter filed Position value Share count Share price at filing
2023-09-30 $384M 227k 1690.00
2022-12-31 $39M 7.6M 5.07

More positions owned by CVI Holdings

Flutter Entmt SHS (FLUT)
Oatly Group Ab Note 9.250% 9/1 (Principal)
Skye Bioscience Com New (SKYE)
Inmune Bio Ord (INMB)
Gp-act Iii Acquisition Corp Unit 99/99/9999 (GPATU)
AZZ Incorporated (AZZ)
Flag Ship Acquisition Corp Unit 05/22/2029 (FSHPU)
Ib Acquisition Corp Com Shs (IBAC)
Haymaker Acquisition Corp Iv Class A (HYAC)
Agriculture & Nat Sol Acq Shs Cl A (ANSC)
Iron Horse Acquisitions Corp (UCFI)
Bayview Acquisition Corp Ord Shs (BAYA)
Trailblazer Merger Corp I Cl A (TBMC)
Nyxoah S A SHS (NYXH)
Goldenstone Acq Crp; Tnt Acq Dt: 12/21/2023; Cash: $10.15 (GDST)

View all positions for CVI Holdings

Top funds holding Immunitybio

Vanguard Group
BlackRock
Jane Street
State Street Corporation
Geode Capital Management
Heights Capital Management
Woodline Partners
Susquehanna International
AlphaCore Capital
Two Sigma Investments
Tang Capital Management
Charles Schwab Investment Management
Citadel Advisors
Northern Trust
UBS Group

View all funds holding Immunitybio